Found 30 results
Author [ Title(Desc)] Type Year
Filters: Author is Davis, MD  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
T. C. Clemons, Ferris, F. L., Chew, E. Y., Davis, M. D., and Group, A. - R. Eye Diseas, “The Age-Related Eye Disease Study (AREDS) Simple Scale: The Relation of the AREDS Simple Scale for AMD to Long-Term Progression to Advanced AMD and Reduced Vision”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2007.
M. D. Davis, Gangnon, R. E., Lee, L. Y., Hubbard, L. D., Klein, B. E., Klein, R., Ferris, F. L., Bressler, S. B., Milton, R. C., and Group, A. - R. Eye Diseas, “The Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration. AREDS Report No. 17”, Arch Ophthalmol, vol. 123, pp. 1484-1498, 2005.
M. Cusick, Meleth, A. D., Agron, E., Fisher, M. R., Reed, G. F., Knatterud, G. L., Barton, F. B., Davis, M. D., Ferris, F. L. 3rd, Chew, E. Y., and Group, E. Treatment, “Associations of Mortality and Diabetes Complications in Patients with Type 1 and Type 2 Diabetes: Early Treatment Diabetic Retinopathy Study Report No. 27”, Diabetes Care, vol. 28, pp. 617-625, 2005.
B
L. P. Aiello, Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., Milton, R. C., and Group, T. P. K. C. D. R. S. 2 S., “Baseline Patient Characteristics in the PKC-DRS2 Trial: The Effect of The PKC-b Inhibitor Ruboxistaurin on Moderate Visual Loss”, in 13th Congress of the European Society of Ophthalmology (SOE) and the 103rd Congress of German Society of Ophthalmology (DOG), Berlin, Germany, 2005.
C
M. L. Klein, Ferris, F. L., Gensler, G., Davis, M. D., Armstrong, J., Chew, E. Y., Bressler, S. B., Gottleib, J., Friberg, T. R., and Group, A. - R. Eye Diseas, “Clinical features and nature course of drusenoid pigment epithelial detachments in age-related macular degeneration”, 2004.
D
M. J. Sheetz, Aiello, L. P., Davis, M. D., Milton, R. C., Arora, V., Hu, K., Girach, A., and Vignati, L., “Diabetic Macular Edema - Relationship of Visual Acuity to Involvement of the Center of the Macula”, 2004.
E
R. C. Milton, Ferris, III, F. L., Gensler, G. R., Ho, M., Davis, M. D., Clemons, T. E., Chew, E. Y., and Group, A. - R. Eye Diseas, “The Effect of Cataract Surgery on the Development of Geographic Atrophy”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2007.
M. J. Sheetz, Aiello, L. P., Davis, M. D., Milton, R. C., Hu, K., Girach, A., and Vignati, L., “The Effect of Riboxistaurin (RBX) on Visual Acuity Loss Due to Diabetic Macular Edema (DME)”, in 15th Scientific Meeting of the Eye Complications Study Group of the European Association for the Study of Diabetes (EASDec), Coimbra, Portugal, 2005.
P. M. Dodson, Aiello, L. P., Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., PKC-DRS, R. C. Milton for, and Groups, P. K. C. - D. R. S. Study, “Effect of Ruboxistaurin on diabetic macular edema and visual loss: Integrated analysis of the PKC-DRS and PKC-DRS2”, 2006.
R. P. Danis, Sheetz, M. J., Aiello, L. P., Davis, M. D., Milton, R. C., Girach, A., Zhi, X., and Group, V. L. for the, “Effect of Ruboxistaurin on reversibility of vision loss in nonproliferative diabetic retinopathy patients”, 2006.
M. J. Sheetz, Aiello, L. P., Davis, M. D., Milton, R. C., Arora, V., Hu, K., Girach, A., and Vignati, L., “The Effect of Ruboxistaurin (RBX), a PKC b Inhibitor, on Visual Acuity (VA) Loss Due to Diabetic Macular Edema (DME)”, 2004.
L. P. Aiello, Vignati, L., ,, Zhi, X., Davis, M. D., Milton, R. C., and Group, G. A. for the, “Effect of the oral PKC b Inhibitor, Ruboxistaurin, on vision loss in patients with diabetic retinopathy: The PKC-DRS2 study results”, 2006.
R. P. Danis, Girach, A., Aiello, L. P., Davis, M. D., Milton, R. C., Sheetz, M. J., Lin, T. E., Zhi, X., and Group, V. L. for the, “The Effect of the Oral PKC b Inhibitor, Ruboxistaurin, on Visual Loss and Diabetic Macular Edema”, in 24th Annual American society of Retinal Specialists and the 6th Annual European Vitreoretinal Society Meeting, Cannes, France, 2006.
L. Vignati, Sheetz, M. J., Girach, A., Zhi, X., Davis, M. D., Milton, R. C., and Group, Afor the P. K., “Effect of the oral protein kinase C b Inhibitor, Ruboxistaurin, on visual acuity in the PKC-DRS2 Study”, 2006.
A. Brucker, Aiello, L. P., Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., and Group, R. C. Milton for, “Effect of the orally administered PKC b Inhibitor, Ruboxistaurin, on sustained moderate visual loss in the PKC-DRS2 Study”, 2006.
L. P. Aiello, Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., and Group, R. C. Milton for, “Effect of the Orally Administered PKC b Inhibitor, Ruboxistaurin, on Visual Acuity in the PKC-DRS2 Study”, 2006.
L. P. Aiello, Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., Milton, R. C., and Group, T. P. K. C. D. R. S. 2 S., “The Effect of the PKC b Inhibitor Ruboxistaurin on Moderate Visual Loss: The PKC-DRS2 Trial Baseline Characteristics and Preliminary Results”, in American Academy of Ophthalmology, Chicago, IL, 2005.
I
J. Armstrong, Davis, M. D., Gangnon, R. E., Lee, L. - Y., Klein, R., Klein, B. E., Milton, R. C., Ferris, F. L., Hubbard, L. D., and Group, A. - R. Eye Diseas, “Illustration of the AMD severity scale from the Age-Related Eye Disease Study”, 2004.
L. P. Aiello, Davis, M. D., Milton, R. C., Sheetz, M. J., Arora, V., Vignati, L., Girach, A., and Group, T. P. K. C. - D. M. E. S. S., “Initial Results of the Protein Kinase C b Inhibitor Diabetic Macular Edema Study (PKC-DMES)”, 2004.
R. C. Milton, Aiello, L. P., Davis, M. D., Arora, V., Vignati, L., Sheetz, M. J., and Group, T. P. K. C. - D. R. S. St, “Initial results of the Protein Kinase C b Inhibitor Diabetic Retinopathy Study (PKC-DRS)”, 2003.
R. C. Milton, Aiello, L. P., Davis, M. D., Sheetz, M. J., Arora, V., and Vignati, L., “Initial results of the Protein Kinase C beta Inhibitor Diabetic Retinopathy Study (PKC-DRS)”, 2003.
L. P. Aiello, Davis, M. D., Milton, R. C., Sheetz, M. J., Arora, V., and Vignati, L., “Initial results of the Protein Kinase C beta Inhibitor Diabetic Macular Edema Study (PKC-DMES)”, 2003.
L
E. Y. Chew, Clemons, T. E., Agron, E., Sperduto, R. D., SanGiovanni, J. P., Kurinij, N., Davis, M. D., and AREDS), A. - R. Eye Diseas, “Long-Term Effects of Vitamins C and E, β-Carotene, and Zinc on Age-Related Macular Degeneration: AREDS Report No. 35”, Opthalmology, vol. 120, pp. 1604-1611e.4, 2013.
R
R. B. Nussenblatt, Kim, J., Thompson, D. J. S., Davis, M. D., Chew, E., Ferris, F. L., and Buggage, R. R., “Randomized Cinical Trial of Vitamin E in the Treatment of Uveitis-Associated Macular Edema”, Am J Ophthalmol, vol. 141, pp. 193-194, 2006.
R. C. Milton, Aiello, L. P., Davis, M. D., Sheetz, M. J., Arora, V., Vignati, L., Girach, A., and Group, T. P. K. C. - D. R. S. St, “Results of the Protein Kinase C b Inhibitor Diabetic Retinopathy Study (PKC-DRS)”, 2004.